Verified Nov 2026
Other
·
Or Akiva, Haifa District
·
Since 1968
Dexcel Pharma, founded in 1968 and headquartered in Or Akiva, Israel, is Israel's private pharmaceutical company with 500–1,000 employees. It develops, manufactures, and markets prescription drugs, generics, and over-the-counter products across cardiovascular, gastroenterological, and central nervous system therapeutic areas, serving 30+ countries. The company acquired US rights to Zubsolv in late 2025 and operates manufacturing facilities in Israel and the UK.
Dexcel Pharma at a glance
Revenue
$50-100M
Est. band
Employees
500-1,000
Founded
1968
Headquarters
Or Akiva, Haifa District
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Dexcel Pharma, founded in 1968 and headquartered in Or Akiva, Israel, is Israel's private pharmaceutical company with 500–1,000 employees. It develops, manufactures, and markets prescription drugs, generics, and over-the-counter products across cardiovascular, gastroenterological, and central nervous system therapeutic areas, serving 30+ countries. The company acquired US rights to Zubsolv in late 2025 and operates manufacturing facilities in Israel and the UK.
At a glance
Attribute | Detail |
|---|---|
Founded | 1968 |
Headquarters | Or Akiva, Haifa District |
Employees | 500-1,000 |
Revenue | $50-100M (estimated) |
What Dexcel Pharma makes
Dexcel specializes in complex drug delivery systems, particularly modified-release technologies, and offers over 85 branded and generic pharmaceuticals in more than 175 dosage forms.
Latest developments
2026-08-11 — Fortissimo sells CTS’s pharma business to Dexcel for $83 million | Ctech (calcalistech.com)
2026-04-08 — Press Release: The approval of Nintedanib Capsules reflects a true cross‑company achievement and a milestone for Dexcel. Developed and manufactured by our team in Israel and successfully launched by Dexcel Pharma USA. | Dexcel Pharma USA (linkedin.com)
2026-01-08 — We're closing out 2025 with another meaningful achievement for the Dexcel Group, this time with Syremis Therapeutics. 🎉 | Dexcel Pharma (linkedin.com)
2026-01-07 — Dexcel Pharma USA Acquires US Rights to Zubsolv® - Dexcel Pharma USA (dexcelpharmausa.com)
2025-12-31 — Orexo closes transaction with Dexcel Pharma USA acquiring full rights to Zubsolv in the US | Orexo (orexo.com)
2025-06-20 — News | Dexcel Pharma's move across Coventry is Bourn (costar.com)
Company details
The company operates research and development centers in Jerusalem and manufacturing facilities in Or Akiva, Yokneam, and Northampton, UK, serving multinational markets including the USA, UK, and Germany. Dexcel Pharma was founded in 1968, has an estimated 500-1,000 employees, and is headquartered in Or Akiva, Haifa District.
Frequently asked questions
What does Dexcel Pharma do?
Dexcel Pharma, founded in 1968 and headquartered in Or Akiva, Israel, is Israel's private pharmaceutical company with 500–1,000 employees. It develops, manufactures, and markets prescription drugs, generics, and over-the-counter products across cardiovascular, gastroenterological, and central nervous system therapeutic areas, serving 30+ countries. The company acquired US rights to Zubsolv in late 2025 and operates manufacturing facilities in Israel and the UK.
Where is Dexcel Pharma headquartered?
Dexcel Pharma is headquartered in Or Akiva, Haifa District.
When was Dexcel Pharma founded?
Dexcel Pharma was founded in 1968.
How big is Dexcel Pharma?
Dexcel Pharma has an estimated 500-1,000 employees, with revenue in the $50-100M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
